Single Biggest Cancer Dictionary in the World
What is
MET tyrosine kinase inhibitor PF-04217903
?Pronunciation: /mɛt tyrosine* kinase* ˌɪnˈhɪbətər pf* fɔr ˈmɪljən, tu ˈhənərd ənd ˈsɛvənˈtin ˈθaʊzənd, naɪn ˈhənərd ənd θri/
MET tyrosine kinase inhibitor PF-04217903
Definition
An orally bioavailabe, small-molecule tyrosine kinase inhibitor of the proto-oncogene c-Met (hepatocyte growth factor receptor [HGFR]) with potential antineoplastic activity. c-Met inhibitor PF-04217903 selectively binds to and inhibits c-Met, disrupting the c-Met signaling pathway, which may result in the inhibition of tumor cell growth, migration and invasion of tumor cells, and the induction of death in tumor cells expressing c-Met. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays key roles in tumor cell proliferation, survival, invasion, metastasis, and tumor angiogenesis.